This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Entamoeba coli

Authoring team

  • Entamoeba coli is a non-pathogenic amoeba (protozoa) with world wide distribution
  • life cycle:
    • similar to that of E. histolytica but it does not have an invasive stage and does not ingest red blood cells
    • organisms exists as a motile trophozoite and a cyst
      • the cyst can survive outside the body and can be transmitted to humans via ingestion of contaminated food or water.
      • may also be spread directly by person-to- person contact (faecal-oral route)
      • whilst the cysts are in the small intestine, the trophozoites emerge, pass down into the colon and then multiply. Cysts and trophozoites are excreted in the faeces. Cysts are then ingested via the faecal-oral route/contaminated food/water
  • trophozoite is larger than that of E. histolytica ranging from 15-50µm in diameter
  • cysts of Entamoeba. coli are 15 - 30 µm in diameter
  • laboratory Diagnosis:
    • made by finding the characteristic cysts in an iodine stained, formol-ether concentration method or by detecting the characteristic trophozoites in a wet preparation or a permanent stained preparation
  • clinical features:
    • presence of these organisms may imply host consumption of fecally contaminated water or food. However, there is no evidence that any of these protozoa have pathogenic potential, even in immunocompromised hosts
  • management: seek expert advice from microbiologist

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.